Earnings Miss: Artivion, Inc. Missed EPS And Analysts Are Revising Their Forecasts
It's been a mediocre week for Artivion, Inc. ( NYSE:AORT ) shareholders, with the stock dropping 13% to US$25.42 in ...
Artivion (NYSE:AORT) Shares Gap Down on Disappointing Earnings
Artivion, Inc. (NYSE:AORT – Get Free Report)’s stock price gapped down before the market opened on Tuesday following a dissappointing earnings announcement. The stock had previously closed at $27.85, ...
Hosted on MSN2d
Artivion (NYSE:AORT) Misses Q4 Sales Targets
Medical device company Artivion (NYSE:AORT) in Q4 CY2024 as sales rose 3.9% year on year to $97.31 million. The company’s ...
StockStory.org on MSN1d
Artivion (AORT) Stock Trades Down, Here Is Why
What Happened? Shares of medical device company Artivion (NYSE:AORT) fell 11.2% in the morning session after the company ...
Artivion reports Q4 non-GAAP EPS 0c, consensus 4c
Reports Q4 revenue $97.3M, consensus $100.82M. “2024 was an excellent year for Artivion (AORT), marked by robust revenue and adjusted EBITDA ...
Artivion: Q4 Earnings Snapshot
The Kennesaw, Georgia-based company said it had a loss of 39 cents per share. Earnings, adjusted for one-time gains and costs, were less than 1 cent on a per-share basis. The biological medical device ...
Finbold | Finance in Bold2d
Suspicious stock trade involving a US Senator delivers massive 100% gains
A suspicious stock trade by Senator Tina Smith saw a $100,000 to $200,000 investment in Artivion, which has since doubled in ...
Artivion Inc (AORT) Q4 2024 Earnings Call Highlights: Revenue Growth Amid Cyber Challenges
Artivion Inc (AORT) reports a 3% revenue increase and a 15% rise in adjusted EBITDA despite a cyber incident impacting Q4 ...